The board of directors of Touyun Biotech Group Limited announced that Mr. Lo Yuen Wa Peter has tendered his resignation as an executive Director with effect from 31 December 2021 as he has reached a retirement age. The Board also announces that Mr. Lo will cease to act as an authorised representative of the Company for the purpose of Rule 3.05 of the Rules Governing the Listing of Securities on the Stock Exchange with effect from 31 December 2021. Mr. Wang Liang, the executive Director and the Chairman of the Company, will be appointed as the Authorised Representative of the Company with effect from 31 December 2021. The Board also announces that Mr. Chen Hui has ceased to be a member of the nomination committee with effect from 31 December 2021. Mr. Chen remains as non- executive Director of the Company. The change was made pursuant to a regular evaluation on the structure and roles of the Nomination Committee and the implementation of Rule 3.27A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited which will come into effect on 1 January 2022.